Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
Peter M.O. Wong
Advertisement
Articles by Peter M.O. Wong
Advertisement
Latest Updated Articles
Closing the Gaps in Drug Chain of CustodyPublished: April 28th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5